<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127886">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02078375</url>
  </required_header>
  <id_info>
    <org_study_id>115687</org_study_id>
    <secondary_id>R03AG045081</secondary_id>
    <nct_id>NCT02078375</nct_id>
  </id_info>
  <brief_title>The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis</brief_title>
  <acronym>PRESSRA</acronym>
  <official_title>The PRESS RA Study: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>American College of Rheumatology Research and Education Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate if the combination of resistance exercise and protein
      supplementation will increase muscle strength and  muscle mass among older individuals with
      rheumatoid arthritis (RA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study proposes a randomized trial to evaluate a tailored 16-week resistance exercise
      program, in combination with protein supplementation, for older individuals with RA. The
      exercise protocol in this study is distinctive because it combines dynamic and isometric
      (static) resistance exercise performed on specialized equipment that can accommodate the
      range of motion limitations frequently encountered in the older RA population. This study
      will also begin to evaluate if additional benefit can be achieved with daily protein
      supplementation
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)</study_design>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>after 16 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by DEXA (lean mass vs fat mass)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>after 16 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by hand grip and biodex</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Carbohydrate supplement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will be enrolled in a twice weekly resistance exercise program. They will receive a carbohydrate supplement to take twice daily (once after exercise).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protein Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be enrolled in a twice weekly resistance exercise program. They will receive a twice daily protein supplement (once after exercise).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein</intervention_name>
    <description>whey protein plus casein protein</description>
    <arm_group_label>Protein Supplementation</arm_group_label>
    <other_name>whey protein plus casein protein</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Carbohydrate (Placebo)</intervention_name>
    <description>The twice daily placebo will consist of a carbohydrate and a small amount of protein</description>
    <arm_group_label>Carbohydrate supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance Exercise Program</intervention_name>
    <description>ALL participants will be enrolled in an individually supervised twice weekly (for 16 weeks) resistance exercise program</description>
    <arm_group_label>Carbohydrate supplement</arm_group_label>
    <arm_group_label>Protein Supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 60-95 years

          -  diagnosis of rheumatoid arthritis

          -  willing to participate in twice weekly exercise sessions

        Exclusion Criteria:

          -  cognitive impairment

          -  recent heart surgery (within past 12 months)

          -  severe kidney disease

          -  use of supplemental oxygen

          -  presence of pacemaker

          -  diabetes that requires insulin for management

          -  allergy to soy or milk
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Manno, MD, MHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca Manno, MD</last_name>
    <phone>410-550-0722</phone>
    <email>rmanno3@jhmi.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Johns Hopkins Bayview Campus</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Manno, MD, MHS</last_name>
      <phone>410-550-0722</phone>
      <email>rmanno3@jhmi.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>March 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Rebecca L Manno</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Rheumatoid Arthritis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
